Ingenuity pathway analysis (IPA) of transcripts downregulated upon CDK9 inhibition revealed significant repression of immune pathways relevant to IBD and other inflammatory disorders including Th1, Th2, and Th17 pathways, and IL-6 and IL-23 signaling (Figure 7, A). The gene discussed is CDK9; the disease is inflammatory bowel disease.